Skip to main content
Clinical Trials/NL-OMON51366
NL-OMON51366
Not yet recruiting
Not Applicable

Evaluating the use of Magnetic Resonance Imaging and Contrast Enhanced Mammography after MagTrace® use - MagTrace 2

Zuyderland Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
breast cancer
Sponsor
Zuyderland Medisch Centrum
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Zuyderland Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • \- Female patients of 18 years and older.
  • \- Previously underwent breast conserving surgery and sentinel lymph node biopsy
  • using MagTrace®.
  • \- Undergoing standard follow\-up for previous breast cancer

Exclusion Criteria

  • \- Unable to comprehend the extend and implications of the study and sign for
  • informed consent.
  • \- Standard MRI exclusion criteria:
  • o Implantable (electrical) devices (e.g., pacemaker, cochlear implants,
  • neurostimulator);
  • o Any other metal implants;
  • o Claustrophobia;
  • o MR\-incompatible prosthetic heart valves.
  • \- Standard CEM exclusion criteria:
  • o Breast implants.

Outcomes

Primary Outcomes

Not specified

Similar Trials